FDA mandates boxed warning for conventional antipsychotics

The FDA announced Monday that older antipsychotics, including thorazine and prolixin, will carry boxed warnings based on data showing that the drugs raise the risk of death when used off-label to treat behavioral symptoms in elderly dementia patients. "This is something we hope [physicians] would discuss with the families and caregivers so they can understand that there are risks to using these drugs," an FDA official said.

View Full Article in:

Washington Post (tiered subscription model), The · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Principal, Global Compliance Operations
DJO Global
Vista, CA
Healthcare Compliance Manager
Ernst & Young
Multiple Locations, SL_Multiple Locations